{
    "id": "0818",
    "question": "A 29-year-old woman presents to her primary care doctor for a prenatal visit. She has just learned that she is pregnant and estimates she is approximately 6 weeks pregnant given the timing of her last menstrual cycle. She has a history of recurrent fetal loss. In total, she has had 4 miscarriages between the gestational ages of 8 and 15 weeks. She has a history of systemic lupus erythematosus and has had several DVTs in the past and a clot in her lung once. Her vitals today are unremarkable. She is asking if there are any treatments she should receive to prevent fetal loss. Which of the following is the most appropriate management of this patient?",
    "options": {
        "A": "Aspirin and heparin",
        "B": "Aspirin and warfarin",
        "C": "No treatment indicated",
        "D": "Rivaroxaban"
    },
    "answer": "A",
    "predict": "Here's the step-by-step thinking for the given question: **Step 1: Identify the patient's medical history and current condition** The patient is a 29-year-old woman with a history of recurrent fetal loss (4 miscarriages between 8 and 15 weeks of gestation), systemic lupus erythematosus (SLE), deep vein thrombosis (DVT), and a pulmonary embolism (PE). She is approximately 6 weeks pregnant. **Step 2: Consider the implications of her medical history on pregnancy** Her history of SLE, DVT, and PE increase her risk of recurrent pregnancy loss and thrombotic complications. SLE can cause antiphospholipid syndrome (APS), which is a known cause of recurrent pregnancy loss. **Step 3: Review the management options for recurrent pregnancy loss and thrombotic complications** For women with a history of recurrent pregnancy loss, the American College of Obstetricians and Gynecologists (ACOG) recommends that women with a history of recurrent pregnancy loss, APS, or thrombotic complications be treated with low-dose aspirin and heparin. **Step 4: Evaluate the treatment options** Option A (Aspirin and heparin) is the most appropriate management for this patient, as it addresses both her history of recurrent pregnancy loss and thrombotic complications. Option B (Aspirin and warfarin) is not recommended as warfarin is not typically used in pregnancy. Option C (No treatment indicated) is incorrect, as this patient has multiple risk factors that require intervention. Option D (Rivaroxaban) is an anticoagulant, but it is not typically used in pregnancy and may not be effective in preventing fetal loss. **Conclusion** The most appropriate management for this patient is Option A: Aspirin and heparin. Here is the output in JSON format: {\"step_by_step_thinking\": \"The patient has a history of recurrent fetal loss, SLE, DVT, and PE, which increase her risk of recurrent pregnancy loss and thrombotic complications. Aspirin and heparin are the recommended treatment for women with these risk factors. Aspirin and heparin are the most appropriate management for this patient.\", \"answer_choice\": \"A\"}",
    "snippets": [
        {
            "id": "Gynecology_Novak_6365",
            "title": "Gynecology_Novak",
            "content": "Many forms of pre-or postconceptional tests have been proposed to help predict pregnancy outcome (201,219,327,462,463); none have been fully substantiated in large, prospective trials. The documentation of fetal cardiac activity on ultrasound may offer prognostic value; however, it appears that its predictions may be greatly affected by any underlying diagnosis. In one study, the live birth rate following documentation of fetal cardiac activity between 5 to 6 weeks from the last menstrual period was approximately 77% in women with two or more unexplained spontaneous abortions (464). It may be important to note that the majority of the patients in this study had evidence of inappropriate antitrophoblast cellular immunity. Others have shown that 86% of patients with antiphospholipid antibodies and recurrent pregnancy loss had fetal cardiac activity detected prior to subsequent demise (465). A prospective, longitudinal, observational study of 325 patients with unexplained recurrent"
        },
        {
            "id": "Obstentrics_Williams_7158",
            "title": "Obstentrics_Williams",
            "content": "The American College of Obstetricians and Gynecologists (2017 c) notes that testing for inherited thrombophilias in women who have experienced recurrent fetal loss or placental abruption is not recommended because clinical evidence that antepartum heparin prophylaxis prevents recurrence is insuicient. Similarly, testing is not recommended for women with a history of fetal-growth restriction or preeclampsia. The American College of Chest Physicians also recommends against screening women with prior pregnancy complications (Bates, TABLE 52-4. How to Test for Thrombophilias Is Testing Is Testing Reliable Reliable Is Testing During During Acute Reliable with Testing Method Pregnancy? Thrombosis? Anticoagulation? alf screening in pregnancy is necessary, cutoff values for free protein S antigen levels in the second and third trimesters been identified at less than 30% and less than 24%, respectively."
        },
        {
            "id": "Pharmacology_Katzung_3849",
            "title": "Pharmacology_Katzung",
            "content": "A 42-year-old woman has heterozygous familial hyper-cholesterolemia (HeFH) but is otherwise well and has no symptoms of coronary or peripheral vascular disease. A carotid ultrasound was normal. Her mother had a myo-cardial infarction at age 51 and had no known risk factors other than her presumed HeFH. The patient also has ele-vated lipoprotein (a) at 2.5 times normal and low HDL-C (43 mg/dL). She developed muscle symptoms with each of 3 statins (atorvastatin, rosuvastatin, and simvastatin) so they were discontinued although she did not develop elevated levels of creatine kinase. Her untreated LDL-C is 235 mg/dL and triglycerides 125 mg/dL. Her LDL-C goal for primary prevention of arteriosclerotic vascular disease is in the 70-mg/dL range because of her multiple lipopro-tein risk factors and her mother\u2019s history of premature coronary artery disease. She has no other risk factors and her diet and exercise habits are excellent. How would you manage this patient?"
        },
        {
            "id": "Pharmacology_Katzung_6809",
            "title": "Pharmacology_Katzung",
            "content": "A 21-year-old woman comes with her parents to discuss therapeutic options for her Crohn\u2019s disease. She was diag-nosed with Crohn\u2019s disease 2 years ago, and it involves her terminal ileum and proximal colon, as confirmed by colonoscopy and small bowel radiography. She was initially treated with mesalamine and budesonide with good response, but over the last 2 months, she has had a relapse of her symptoms. She is experiencing fatigue, cramping, abdominal pains, and nonbloody diarrhea up to 10 times daily, and she has had a 15-lb weight loss. She has no other significant medical or surgical his-tory. Her current medications are mesalamine 2.4 g/d and budesonide 9 mg/d. She appears thin and tired. Abdominal examination reveals tenderness without guarding in the right lower quadrant; no masses are palpable. On perianal examination, there is no tenderness, fissure, or fistula. Her laboratory data are notable for anemia and elevated C-reactive protein. What are the options for immediate"
        },
        {
            "id": "Pharmacology_Katzung_5171",
            "title": "Pharmacology_Katzung",
            "content": "A 59-year-old woman presents to an urgent care clinic with a 4-day history of frequent and painful urination. She has had fevers, chills, and flank pain for the past 2 days. Her physician advised her to come immediately to the clinic for evaluation. In the clinic she is febrile (38.5\u00b0C [101.3\u00b0F]) but otherwise stable and states she is not experiencing any nausea or vomiting. Her urine dipstick test is positive for leukocyte esterase. Urinalysis and urine culture are ordered. Her past medical history is significant for three urinary tract infections in the past year. Each episode was uncom-plicated, treated with trimethoprim-sulfamethoxazole, and promptly resolved. She also has osteoporosis for which she takes a daily calcium supplement. The decision is made to treat her with oral antibiotics for a complicated urinary tract infection with close follow-up. Given her history, what would be a reasonable empiric antibiotic choice? Depending on the antibiotic choice are there potential drug"
        },
        {
            "id": "Pharmacology_Katzung_3731",
            "title": "Pharmacology_Katzung",
            "content": "James L. Zehnder, MD and edema and is tender to touch. Oxygen saturation by fingertip pulse oximeter while breathing room air is 87% (normal > 90%). Ultrasound reveals a deep vein thrombosis in the left lower extremity; chest computed tomography scan confirms the presence of pulmonary emboli. Laboratory blood tests indicate elevated d-dimer levels. What therapy is indicated acutely? What are the long-term therapy options? How long should she be treated? Should this indi-vidual use oral contraceptives? A 25-year-old woman presents to the emergency depart-ment complaining of acute onset of shortness of breath and pleuritic pain. She had been in her usual state of health until 2 days prior when she noted that her left leg was swollen and red. Her only medication was oral contraceptives. Family history was significant for a history of \u201cblood clots\u201d in mul-tiple members of the maternal side of her family. Physical examination demonstrates an anxious woman with stable vital signs. The left"
        },
        {
            "id": "Pharmacology_Katzung_3234",
            "title": "Pharmacology_Katzung",
            "content": "What CYP450 and pharmacodynamic interactions might be associated with fluoxetine use in this patient? Which class of antidepressants would be contraindicated in this patient? A 47-year-old woman presents to her primary care physician with a chief complaint of fatigue. She indicates that she was promoted to senior manager in her company approximately 11 months earlier. Although her promotion was welcome and came with a sizable raise in pay, it resulted in her having to move away from an office and group of colleagues she very much enjoyed. In addition, her level of responsibility increased dramatically. The patient reports that for the last 7 weeks, she has been waking up at 3 am every night and been unable to go back to sleep. She dreads the day and the stresses of the workplace. As a consequence, she is not eating as well as she might and has dropped 7% of her body weight in the last 3 months. She also reports being so stressed that she breaks down crying in the office occasionally"
        },
        {
            "id": "Pharmacology_Katzung_2047",
            "title": "Pharmacology_Katzung",
            "content": "Joshua M. Galanter, MD, & Homer A. Boushey, MD and respirations are 32/min. Her mother states that she has used her albuterol inhaler several times a day for the past 3 days and twice during the previous night. She took an additional two puffs on her way to the emergency department, but her mother states that \u201cthe inhaler didn\u2019t seem to be helping so I told her not to take any more.\u201d What emergency measures are indicated? How should her long-term management be altered? A 14-year-old girl with a history of asthma requiring daily inhaled corticosteroid therapy and allergies to house dust mites, cats, grasses, and ragweed presents to the emergency department in mid-September, reporting a recent \u201ccold\u201d com-plicated by worsening shortness of breath and audible inspi-ratory and expiratory wheezing. She appears frightened and refuses to lie down but is not cyanotic. Her pulse is 120 bpm,"
        },
        {
            "id": "Pharmacology_Katzung_5050",
            "title": "Pharmacology_Katzung",
            "content": "Camille E. Beauduy, PharmD, & Lisa G. Winston, MD motion tenderness is present. A first-catch urine specimen is obtained for chlamydia and gonorrhea nucleic acid amplifi-cation testing. A urine pregnancy test is also ordered as the patient reports she \u201cmissed her last period.\u201d Pending these results, the decision is made to treat her presumptively for chlamydial cervicitis. What are two potential treatment options for her possible chlamydial infection? How does her potential pregnancy affect the treatment decision? A 22-year-old woman presents to her college medical clinic complaining of a 2-week history of vaginal discharge. She denies any fever or abdominal pain but does report vaginal bleeding after sexual intercourse. When questioned about her sexual activity, she reports having vaginal intercourse, at times unprotected, with two men in the last 6 months. A pelvic examination is performed and is positive for muco-purulent discharge from the endocervical canal. No cervical"
        },
        {
            "id": "Gynecology_Novak_4465",
            "title": "Gynecology_Novak",
            "content": "History A thorough medical history should be obtained from every incontinent patient. The history should include a review of symptoms, general medical history, review of past surgery, and current medications. The woman\u2019s most troubling symptoms must be ascertained\u2014how often she leaks urine, how much urine she leaks, what provokes urine loss, what improves or worsens the problem, and what treatment (if any) she had in the past. It is essential to keep the patient\u2019s chief symptom at the forefront to avoid inappropriate management. Consider, for example, a woman whose chief concern is that once a month, while leading a business seminar, she has a sudden, overwhelming urge to void followed by complete bladder emptying. She finds this leakage devastating and is considering quitting her job because of her acute embarrassment. On occasion, she leaks a few drops of urine during exercise, but this minor leakage does not bother her. During the evaluation, urodynamics reveal minimal stress"
        },
        {
            "id": "Pharmacology_Katzung_4444",
            "title": "Pharmacology_Katzung",
            "content": "The Gonadal Hormones & Inhibitors George P. Chrousos, MD A 25-year-old woman with menarche at 13 years and menstrual periods until about 1 year ago complains of hot flushes, skin and vaginal dryness, weakness, poor sleep, and scanty and infrequent menstrual periods of a year\u2019s dura-tion. She visits her gynecologist, who obtains plasma levels of follicle-stimulating hormone and luteinizing hormone, both of which are moderately elevated. She is diagnosed with premature ovarian failure, and estrogen and pro-gesterone replacement therapy is recommended. A dual-energy absorptiometry scan (DEXA) reveals a bone density t-score of <2.5 SD, ie, frank osteoporosis. How should the ovarian hormones she lacks be replaced? What extra mea-sures should she take for her osteoporosis while receiving treatment? \u25a0 THE OVARY (ESTROGENS, PROGESTINS, OTHER OVARIAN HORMONES, ORAL CONTRACEPTIVES, INHIBITORS & ANTAGONISTS, & OVULATIONINDUCING AGENTS)"
        },
        {
            "id": "Pharmacology_Katzung_1897",
            "title": "Pharmacology_Katzung",
            "content": "The Eicosanoids: Prostaglandins, Thromboxanes, Leukotrienes, & Related Compounds John Hwa, MD, PhD, & Kathleen Martin, PhD* pulmonary pressures, and right ventricular enlargement. Cardiac catheterization confirmed the severely elevated pulmonary pressures. She was commenced on appropri-ate therapies. Which of the eicosanoid agonists have been demonstrated to reduce both morbidity and mortality in patients with such a diagnosis? What are the modes of action? A 40-year-old woman presented to her doctor with a 6-month history of increasing shortness of breath. This was associated with poor appetite and ankle swell-ing. On physical examination, she had elevated jugular venous distention, a soft tricuspid regurgitation murmur, clear lungs, and mild peripheral edema. An echocardio-gram revealed tricuspid regurgitation, severely elevated"
        },
        {
            "id": "Pharmacology_Katzung_2257",
            "title": "Pharmacology_Katzung",
            "content": "Anthony J. Trevor, PhD not overweight, and she takes no prescription drugs. She drinks decaffeinated coffee but only one cup in the morning; however, she drinks as many as six cans per day of diet cola. She drinks a glass of wine with her evening meal but does not like stronger spirits. What other aspects of this patient\u2019s history would you like to know? What therapeutic measures are appropriate for this patient? What drug, or drugs, (if any) would you prescribe? At her annual physical examination, a 53-year-old middle school teacher complains that she has been having difficulty falling asleep, and after falling asleep, she awakens several times during the night. These episodes now occur almost nightly and are interfering with her ability to teach. She has tried various over-the-counter sleep remedies, but they were of little help and she experienced \u201changover\u201d effects on the day following their use. Her general health is good, she is"
        },
        {
            "id": "Obstentrics_Williams_4419",
            "title": "Obstentrics_Williams",
            "content": "Delivery at 39 weeks' gestation is recommended. Labor induction is suitable, and cesarean delivery is elected for those with a contraindication to induction. his timing minimizes TABLE 35-3. Management of Subsequent Pregnancy after Stillbirth Review evaluation of prior stillbirth Determination of recurrence risk Discuss recurrence of comorbid obstetric complications Thrombophilia screen: antiphospholipid antibodies First-trimester screen: pregnancy-associated plasma protein A, human chorionic gonadotropin, and nuchal Sonographic screening for fetal-growth restriction, Delivery before 39 weeks only with documented fetal aprovides risk modification but does not alter management. Modified from Reddy, 2007. fetal mortality rates, although the degree of risk reduction may be greater for older women (Page, 2013)."
        },
        {
            "id": "Pharmacology_Katzung_5664",
            "title": "Pharmacology_Katzung",
            "content": "Philip J. Rosenthal, MD A 5-year-old American girl presents with a 1-week history of intermittent chills, fever, and sweats. She had returned home 2 weeks earlier after leaving the USA for the first time to spend 3 weeks with her grandparents in Nigeria. She received all standard childhood immunizations, but no additional treat-ment before travel, since her parents have returned to their native Nigeria frequently without medical consequences. Three days ago, the child was seen in an outpatient clinic and diagnosed with a viral syndrome. Examination reveals a lethargic child, with a temperature of 39.8\u00b0C (103.6\u00b0F) and splenomegaly. She has no skin rash or lymphadenopathy. Ini-tial laboratory studies are remarkable for hematocrit 29.8%, platelets 45,000/mm3, creatinine 2.5 mg/dL (220 \u03bcmol/L), and mildly elevated bilirubin and transaminases. A blood smear shows ring forms of Plasmodium falciparum at 1.5% parasit-emia. What treatment should be started?"
        },
        {
            "id": "Pharmacology_Katzung_5336",
            "title": "Pharmacology_Katzung",
            "content": "Sharon Safrin, MD A 35-year-old white woman who recently tested seropositive for both HIV and hepatitis B virus surface antigen is referred for evaluation. She is feeling well overall but reports a 25-pack-year smoking history. She drinks 3\u20134 beers per week and has no known medication allergies. She has a history of heroin use and is currently receiving methadone. Physical examination reveals normal vital signs and no abnormalities. White blood cell count is 5800 cells/mm3 with a normal differential, hemoglobin is 11.8 g/dL, all liver tests are within normal limits, CD4 cell count is 278 cells/mm3, and viral load (HIV RNA) is 110,000 copies/mL. What other laboratory tests should be ordered? Which antiretroviral medica-tions would you begin?"
        },
        {
            "id": "Biochemistry_Lippincott_1244",
            "title": "Biochemistry_Lippinco",
            "content": "Choose the ONE best answer. For Questions 26.1 and 26.2, use the following scenario. A 40-year-old woman, 5 ft, 1 in (155 cm) tall and weighing 188 lb (85.5 kg), seeks your advice on how to lose weight. Her waist measured 41 in and her hips 39 in. The remainder of the physical examination and the blood laboratory data were all within the normal range. Her only child (who is age 14 years), her sister, and both of her parents are overweight. The patient recalls being overweight throughout her childhood and adolescence. Over the past 15 years, she had been on seven different diets for periods of 2 weeks to 3 months, losing from 5 to 25 lb each time. On discontinuation of the diets, she regained weight, returning to 185\u2013190 lb. 6.1. Calculate and interpret the body mass index for the patient. Body mass index (BMI) = weight in kg/(height in m)2 = 85.5/1.552 = 35.6. Because her BMI is >30, the patient is classified as obese."
        },
        {
            "id": "Gynecology_Novak_6188",
            "title": "Gynecology_Novak",
            "content": "Parental chromosomal abnormalities and thrombotic complications of the antiphospholipid antibody syndrome (APS) are the only undisputed causes of recurrent abortion. However, collectively these abnormalities account for less than 10% to 15% of recurrent pregnancy losses. Although the exact proportion of patients diagnosed with a particular abnormality may vary among the populations studied, other associations have been made with anatomic abnormalities (12%\u201316%), endocrine problems (17%\u201320%), infections (0.5%\u20135%), and immunologic factors, including those associated with the APS (20%\u201350%). Other miscellaneous factors have been implicated and account for approximately 10% of cases. Among women aged 35 or greater who experience recurrent pregnancy loss, spontaneous fetal chromosomal abnormalities are likely to be responsible for the vast majority of losses (8). Even after a thorough evaluation, the potential cause remains unexplained in about one-third to one-half of all cases of"
        },
        {
            "id": "Pharmacology_Katzung_7019",
            "title": "Pharmacology_Katzung",
            "content": "Her social history is significant for alcohol use (three to four glasses of wine/night). Her vital signs include the following: temperature 99.8\u00b0F, blood pressure 132/64 mm Hg, pulse 78 bpm, and respiratory rate 15/min. On physical examination, she had left upper abdominal tenderness with evidence of hepatomegaly and mild scleral icterus. Laboratory data revealed the following: alanine aminotransferase, 527 IU/L (normal 10\u201335 IU/L); aspartate aminotransferase, 425 IU/L (normal < 35 IU/L); and bilirubin, 2.9 mg/dL (normal 0.1\u20130.3 mg/dL). What medications do OTC cold and flu preparations typically contain? Which of the OTC medications might have contrib-uted to the patient\u2019s current symptoms? KH, a 55-year-old woman, presents to the emergency department with nausea, vomiting, and complaints of new-onset flu symptoms over the past several days. Her past medical history is significant for allergic rhinitis and chronic lower back pain secondary to a work-related fall 2 years ago. Her"
        },
        {
            "id": "Gynecology_Novak_6317",
            "title": "Gynecology_Novak",
            "content": "If a pregnancy has been confirmed, but fetal cardiac activity cannot be documented by approximately 6 to 7 weeks of gestation (by sure menstrual or ultrasonographic dating), intervention is recommended to expedite pregnancy termination and to obtain tissue for karyotype analysis. First trimester screening with maternal chemistries and fetal nuchal lucency measurement or chorionic villus sampling are recommended for obstetrical indications. Maternal serum can also be obtained for assessment at 16 to 18 weeks of gestation. Amniocentesis may be recommended to assess the fetal karyotype after the pregnancy has progressed past the time of prior losses."
        },
        {
            "id": "Pharmacology_Katzung_7061",
            "title": "Pharmacology_Katzung",
            "content": "A 53-year-old woman with a history of knee osteoarthritis, high cholesterol, type 2 diabetes, and hypertension presents with new onset of hot flashes and a question about a dietary supplement. She is obese (body mass index [BMI] 33), does not exercise, and spends a good portion of her work day in a seated position. She eats a low-sugar diet and regularly eats packaged frozen meals for dinner because she doesn\u2019t have time to cook regularly. Her most recent laboratory values include a low-density lipoprotein (LDL) cholesterol that is above goal at 160 mg/dL (goal < 100 mg/dL) and a hemo-globin A1c that is well controlled at 6%. Her blood pressure is high at 160/100 mm Hg. Her prescription medications include simvastatin, metformin, and benazepril. She also takes over-the-counter ibuprofen for occasional knee pain and a multivitamin supplement once daily. She has heard good things about natural products and asks you if taking a garlic supplement daily could help to bring her blood"
        },
        {
            "id": "Biochemistry_Lippincott_1935",
            "title": "Biochemistry_Lippinco",
            "content": "A. Alanine B. Ammonia C. Glutamine D. Insulin E. pH Case 10: Calf Pain Patient Presentation: CR is a 19-year-old female who is being evaluated for pain and swelling in her right calf. Focused History: Ten days ago, CR had her spleen removed following a bicycle accident in which she fractured her tibial eminence, necessitating immobilization of the right knee. She has had a good recovery from the surgery. CR is no longer taking pain medication but has continued her oral contraceptives (OCP). Pertinent Findings: CR\u2019s right calf is reddish in color (erythematous) and warm to the touch. It is visibly swollen. The left calf is normal in appearance and is without pain. An ultrasound is ordered. Diagnosis: CR has a deep venous thrombosis (DVT). OCP are a risk factor for DVT, as are surgery and immobilization. Treatment (Immediate): Heparin and warfarin are administered. Prognosis: In the 10 years following a DVT, about one third of individuals have a recurrence."
        },
        {
            "id": "Anatomy_Gray_1667",
            "title": "Anatomy_Gray",
            "content": "A 28-year-old woman was seen by her family practitioner for a routine pregnancy checkup at 36 weeks\u2019 gestational age. Neither the patient nor the family physician had any concerns about the pregnancy. However, the patient did complain of unilateral swelling of her left leg, which had gradually increased over the previous 2 days. Furthermore, the evening before her visit she developed some sharp chest pain, which was exacerbated by deep breaths. The family physician ordered a duplex ultrasound scan of the left leg venous system. Ultrasound scanning of the vascular tree can demonstrate flow and occlusion of arteries and veins."
        },
        {
            "id": "Pharmacology_Katzung_1130",
            "title": "Pharmacology_Katzung",
            "content": "Irbesartan Generic,Avapro Treatment of Angina Pectoris Bertram G. Katzung, MD, PhD* A 56-year-old woman presents in the office with a history of recent-onset chest discomfort when jogging or swimming vigorously. The pain is dull but poorly localized; it disap-pears after 5\u201310 minutes of rest. She has never smoked but has a history of hyperlipidemia (total cholesterol level of 245 mg/dL and low-density lipoprotein [LDL] of 160 mg/dL recorded 1 year ago) and admits that she has not been fol-lowing the recommended diet. Her father survived a \u201cheart attack\u201d at age 55, and an uncle died of some cardiac disease at age 60. On physical examination, the patient\u2019s blood pressure is 145/90 mm Hg, and her heart rate is 80 bpm. She is in no acute distress, and there are no other significant physical findings; an electrocardiogram is normal except for slight left ventricular hypertrophy. Assuming that a diagno-sis of stable effort angina is correct, what medical treatment should be implemented?"
        },
        {
            "id": "Biochemistry_Lippincott_175",
            "title": "Biochemistry_Lippinco",
            "content": "Choose the ONE best answer. .1. A 30-year-old woman of Northern European ancestry presents with progressive dyspnea (shortness of breath). She denies the use of cigarettes. Family history reveals that her sister also has problems with her lungs. Which one of the following etiologies most likely explains this patient\u2019s pulmonary symptoms? A. Deficiency in dietary vitamin C B. Deficiency of \u03b11-antitrypsin C. Deficiency of prolyl hydroxylase D. Decreased elastase activity E. Increased collagenase activity"
        },
        {
            "id": "Pharmacology_Katzung_6478",
            "title": "Pharmacology_Katzung",
            "content": "Management of the Poisoned Patient Kent R. Olson, MD A 62-year-old woman with a history of depression is found in her apartment in a lethargic state. An empty bottle of bupro-pion is on the bedside table. In the emergency department, she is unresponsive to verbal and painful stimuli. She has a brief generalized seizure, followed by a respiratory arrest. The emergency physician performs endotracheal intubation and administers a drug intravenously, followed by another sub-stance via a nasogastric tube. The patient is admitted to the intensive care unit for continued supportive care and recovers the next morning. What drug might be used intravenously to prevent further seizures? What substance is commonly used to adsorb drugs still present in the gastrointestinal tract?"
        },
        {
            "id": "Gynecology_Novak_6301",
            "title": "Gynecology_Novak",
            "content": "Most women with recurrent pregnancy losses tend to experience spontaneous abortion at approximately the same gestational age in sequential pregnancies (321). Unfortunately, the gestational age when pregnancy loss occurs, as determined by last menstrual period, may not be informative, because there is often a 2-to 3-week delay between fetal demise and signs of pregnancy expulsion (322). The designation of couples experiencing recurrent abortion into either primary or secondary categories is not helpful in either the diagnosis or management of most women with recurrent abortion. Approximately 10% to 15% of couples cannot be classified into either the primary or secondary category because, although their first pregnancy resulted in a loss, it was followed by a term delivery prior to subsequent losses."
        },
        {
            "id": "Pharmacology_Katzung_3233",
            "title": "Pharmacology_Katzung",
            "content": "Charles DeBattista, MD house and has no motivation, interest, or energy to pursue recreational activities that she once enjoyed such as hiking. She describes herself as \u201cchronically miserable and worried all the time.\u201d Her medical history is notable for chronic neck pain from a motor vehicle accident for which she is being treated with tramadol and meperidine. In addition, she is on hydrochlorothiazide and propranolol for hypertension. The patient has a history of one depressive episode after a divorce that was treated successfully with fluoxetine. Medical workup including complete blood cell count, thyroid func-tion tests, and a chemistry panel reveals no abnormalities. She is started on fluoxetine for a presumed major depressive episode and referred for cognitive behavioral psychotherapy. What CYP450 and pharmacodynamic interactions might be associated with fluoxetine use in this patient? Which class of antidepressants would be contraindicated in this patient? A 47-year-old woman"
        },
        {
            "id": "Gynecology_Novak_6186",
            "title": "Gynecology_Novak",
            "content": "Traditionally, recurrent abortion has been defined as the occurrence of three or more clinically recognized pregnancy losses before 20 weeks from the last menstrual period. Using this definition, recurrent pregnancy loss occurs in approximately 1 in 300 pregnancies (2). Clinical investigation of pregnancy loss, however, may be initiated after two consecutive spontaneous abortions, especially when fetal heart activity is identified before any of the pregnancy losses, when the women is older than 35 years of age, or when the couple has had difficulty conceiving (5). A study of over 1,000 patients with recurrent pregnancy loss reported no difference in the prevalence of abnormal results for evidence-based and investigative diagnostic tests when the diagnostic workup was initiated after two versus three or more losses (6). If clinical intervention is undertaken in the form of investigation after two spontaneous abortions, approximately 1% of pregnant women will require evaluation (3)."
        },
        {
            "id": "Obstentrics_Williams_8253",
            "title": "Obstentrics_Williams",
            "content": "Fetal loss is common in women with APS if untreated (Rai, 1995). Even with treatment, recurrent fetal loss rates remain at 20 to 30 percent (Branch, 2003; Empson, 2005; Ernest, 2011). Shown in Table 59-6 are pregnancy outcomes from 750 treated women with primary APS-the PREGNANTS study (Saccone, 2017). Participants were treated with low-dose aspirin and prophylactic low-molecular-weight heparin starting in the irst trimester. Importantly, some women with SLE and antiphospholipid antibodies have normal pregnancy outcomes without treatment. Also, it is emphasized that women with LAC and prior bad pregnancy outcomes have had liveborn neonates without treatment."
        },
        {
            "id": "Pharmacology_Katzung_2439",
            "title": "Pharmacology_Katzung",
            "content": "Roger J. Porter, MD, & Michael A. Rogawski, MD, PhD was unchanged, and levetiracetam was gradually increased to 1000 mg bid. The patient had no significant adverse effects from this dosage. At age 21, she had a second tonic-clonic seizure while in college; further discussion with her room-mate at that time revealed a history of two recent episodes of 1\u20132 minutes of altered consciousness with lip smacking (focal impaired awareness seizure, formerly complex partial seizure). A repeat EEG showed occasional right temporal spikes. What is one possible strategy for controlling her present symptoms? A 23-year-old woman presents to the office for consultation regarding her antiseizure medications. Seven years ago, this otherwise healthy young woman had a tonic-clonic seizure at home. She was rushed to the emergency department, at which time she was alert but complained of headache. A consulting neurologist placed her on levetiracetam, 500 mg bid. Four days later, electroencephalography (EEG)"
        },
        {
            "id": "Pharmacology_Katzung_545",
            "title": "Pharmacology_Katzung",
            "content": "Introduction to Autonomic Pharmacology Bertram G. Katzung, MD, PhD A 56-year-old woman is brought to the university eye center with a complaint of \u201closs of vision.\u201d Because of visual impair-ment, she has lost her driver\u2019s license and has fallen several times in her home. Examination reveals that her eyelids close involuntarily with a frequency and duration sufficient to pre-vent her from seeing her surroundings for more than brief moments at a time. When she holds her eyelids open with her fingers, she can see normally. She has no other muscle dysfunction. A diagnosis of blepharospasm is made. Using a fine needle, several injections of botulinum toxin type A are made in the orbicularis oculi muscle of each eyelid. After observation in the waiting area, she is sent home. Two days later, she reports by telephone that her vision has improved dramatically. How did botulinum toxin improve her vision? How long can her vision be expected to remain normal after this single treatment?"
        }
    ],
    "scores": [
        0.024119062917520834,
        0.022884110294182237,
        0.01896117900790798,
        0.018783068783068783,
        0.018672919923571306,
        0.01827849783981389,
        0.01823607427055703,
        0.01805465191932336,
        0.017946241751166908,
        0.01793400286944046,
        0.01783749803551784,
        0.017523809523809525,
        0.01743877473652286,
        0.01726660813579163,
        0.017170228445099484,
        0.01700800793707037,
        0.016979638822936904,
        0.016892373485388454,
        0.01675320179993077,
        0.016567656765676567,
        0.016541865214431586,
        0.01641641641641642,
        0.01627737709256931,
        0.016036949130797357,
        0.015741253151325095,
        0.0156981039152918,
        0.015621370499419281,
        0.015563732882910056,
        0.015485739750445633,
        0.015385525770755665,
        0.015326340326340327,
        0.015297998180163785
    ]
}